Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Cash & Equivalents Growth (3y) (2023 - 2026)

Analysis

Treace Medical Concepts (TMCI) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -13.31%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -7.03%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 8.09%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 34.27%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 8.16%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 40.74%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 27.03%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -2.57%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 32.23%
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn 1.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.57%
Mar 31, 2026 -31.44%
Dec 31, 2025 -18.07%
Sep 30, 2025 -55.72%
Jun 30, 2025 -57.04%
Mar 31, 2025 -48.60%
Dec 31, 2024 -52.49%
Sep 30, 2024 -51.99%
Jun 30, 2024 -46.63%
Mar 31, 2024 -16.82%
Dec 31, 2023 -10.45%
Sep 30, 2023 -22.10%
Jun 30, 2023 5.31%
Mar 31, 2023 40.83%